<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Muhammad T</submitter><funding>Elisabeth and Alfred Ahlqvists stiftelse</funding><funding>Swedish Research Council</funding><funding>Elisabeth and Alfred Ahlqvists stiftelse postdoctoral scholarship</funding><pagination>504</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9953701</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(2)</volume><pubmed_abstract>Is it possible to enhance structural stability and biological activity of KR-12, a truncated antimicrobial peptide derived from the human host defense peptide LL-37? Based on the mapping of essential residues in KR-12, we have designed backbone-cyclized dimers, cross-linked via a disulfide bond to improve peptide stability, while at the same time improving on-target activity. Circular dichroism showed that each of the dimers adopts a primarily alpha-helical conformation (55% helical content) when bound to lyso-phosphatidylglycerol micelles, indicating that the helical propensity of the parent peptide is maintained in the new cross-linked cyclic form. Compared to KR-12, one of the cross-linked dimers showed 16-fold more potent antimicrobial activity against human pathogens &lt;i>Pseudomonas ae</pubmed_abstract><journal>Biomedicines</journal><pubmed_title>Transforming Cross-Linked Cyclic Dimers of KR-12 into Stable and Potent Antimicrobial Drug Leads.</pubmed_title><pmcid>PMC9953701</pmcid><funding_grant_id>Medicine and Health, #2011-03403; UG</funding_grant_id><funding_grant_id>Postdoctoral Scholarship: TM</funding_grant_id><funding_grant_id>#2011-03403</funding_grant_id><pubmed_authors>Gunasekera S</pubmed_authors><pubmed_authors>Muhammad T</pubmed_authors><pubmed_authors>Stromstedt AA</pubmed_authors><pubmed_authors>Goransson U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transforming Cross-Linked Cyclic Dimers of KR-12 into Stable and Potent Antimicrobial Drug Leads.</name><description>Is it possible to enhance structural stability and biological activity of KR-12, a truncated antimicrobial peptide derived from the human host defense peptide LL-37? Based on the mapping of essential residues in KR-12, we have designed backbone-cyclized dimers, cross-linked via a disulfide bond to improve peptide stability, while at the same time improving on-target activity. Circular dichroism showed that each of the dimers adopts a primarily alpha-helical conformation (55% helical content) when bound to lyso-phosphatidylglycerol micelles, indicating that the helical propensity of the parent peptide is maintained in the new cross-linked cyclic form. Compared to KR-12, one of the cross-linked dimers showed 16-fold more potent antimicrobial activity against human pathogens &lt;i>Pseudomonas ae</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-04-08T14:33:04.234Z</modification><creation>2025-02-18T23:44:22.418Z</creation></dates><accession>S-EPMC9953701</accession><cross_references><pubmed>36831040</pubmed><doi>10.3390/biomedicines11020504</doi></cross_references></HashMap>